Total Payments
$108,421
2024 Payments
$18.09
Companies
3
Transactions
68
Medicare Patients
253
Medicare Billing
$29,455
Payment Breakdown by Category
Other$98,050 (90.4%)
Travel$6,189 (5.7%)
Consulting$2,398 (2.2%)
Food & Beverage$1,748 (1.6%)
Education$37.10 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $98,050 | 24 | 90.4% |
| Travel and Lodging | $6,189 | 19 | 5.7% |
| Consulting Fee | $2,398 | 1 | 2.2% |
| Food and Beverage | $1,748 | 22 | 1.6% |
| Education | $37.10 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $108,356 | 66 | $0 (2021) |
| TESARO, Inc. | $46.66 | 1 | $0 (2019) |
| Merck Sharp & Dohme LLC | $18.09 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.09 | 1 | Merck Sharp & Dohme LLC ($18.09) |
| 2021 | $19.01 | 1 | AstraZeneca Pharmaceuticals LP ($19.01) |
| 2020 | $28,572 | 12 | AstraZeneca Pharmaceuticals LP ($28,572) |
| 2019 | $78,888 | 48 | AstraZeneca Pharmaceuticals LP ($78,841) |
| 2018 | $924.35 | 6 | AstraZeneca Pharmaceuticals LP ($924.35) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/29/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Education | In-kind items and services | $18.09 | General |
| Category: ONCOLOGY | ||||||
| 10/26/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Education | In-kind items and services | $19.01 | General |
| Category: Oncology | ||||||
| 03/18/2020 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,500.00 | General |
| Category: Oncology | ||||||
| 03/10/2020 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,500.00 | General |
| Category: Oncology | ||||||
| 03/05/2020 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Travel and Lodging | In-kind items and services | $561.80 | General |
| Category: Oncology | ||||||
| 03/05/2020 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 03/05/2020 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Travel and Lodging | In-kind items and services | $84.36 | General |
| Category: Oncology | ||||||
| 02/18/2020 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: Oncology | ||||||
| 02/05/2020 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $133.51 | General |
| Category: Oncology | ||||||
| 01/29/2020 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,500.00 | General |
| Category: Oncology | ||||||
| 01/23/2020 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Travel and Lodging | In-kind items and services | $101.20 | General |
| Category: Oncology | ||||||
| 01/23/2020 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $65.89 | General |
| Category: Oncology | ||||||
| 01/02/2020 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,500.00 | General |
| Category: Oncology | ||||||
| 01/02/2020 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: Oncology | ||||||
| 12/19/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Travel and Lodging | In-kind items and services | $183.28 | General |
| Category: Oncology | ||||||
| 12/19/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $96.04 | General |
| Category: Oncology | ||||||
| 12/18/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $107.73 | General |
| Category: Oncology | ||||||
| 11/27/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $2,397.50 | General |
| Category: Oncology | ||||||
| 11/04/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,500.00 | General |
| Category: Oncology | ||||||
| 10/28/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Travel and Lodging | In-kind items and services | $471.60 | General |
| Category: Oncology | ||||||
| 10/28/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $124.49 | General |
| Category: Oncology | ||||||
| 10/24/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Oncology | ||||||
| 10/06/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,500.00 | General |
| Category: Oncology | ||||||
| 10/01/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Travel and Lodging | In-kind items and services | $441.00 | General |
| Category: Oncology | ||||||
| 10/01/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 65 | 77 | $45,008 | $9,162 |
| 2022 | 3 | 48 | 52 | $24,713 | $5,607 |
| 2021 | 3 | 54 | 56 | $18,746 | $4,856 |
| 2020 | 5 | 86 | 104 | $35,681 | $9,831 |
Total Patients
253
Total Services
289
Medicare Billing
$29,455
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 29 | $17,980 | $3,668 | 20.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 25 | $11,000 | $2,124 | 19.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $9,120 | $1,859 | 20.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 11 | 11 | $6,908 | $1,511 | 21.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $18,382 | $4,135 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 13 | $5,382 | $1,249 | 23.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 11 | 13 | $949.00 | $222.99 | 23.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 21 | 21 | $13,881 | $3,708 | 26.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 14 | $3,332 | $756.54 | 22.7% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 20 | 21 | $1,533 | $390.60 | 25.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 19 | 19 | $11,837 | $3,326 | 28.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 18 | 18 | $8,910 | $2,388 | 26.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 22 | $7,194 | $1,935 | 26.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 21 | 30 | $6,720 | $1,864 | 27.7% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 15 | 15 | $1,020 | $319.14 | 31.3% |
About Dr. Levi Downs, M.D
Dr. Levi Downs, M.D is a Gynecologic Oncology healthcare provider based in St Louis Park, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700816311.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Levi Downs, M.D has received a total of $108,421 in payments from pharmaceutical and medical device companies, with $18.09 received in 2024. These payments were reported across 68 transactions from 3 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($98,050).
As a Medicare-enrolled provider, Downs has provided services to 253 Medicare beneficiaries, totaling 289 services with total Medicare billing of $29,455. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Obstetrics & Gynecology
- Location St Louis Park, MN
- Active Since 07/03/2006
- Last Updated 12/11/2019
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1700816311
Products in Payments
- LYNPARZA (Drug) $108,356
- ZEJULA (Drug) $46.66
- KEYTRUDA (Biological) $18.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.